|
|
Suppliers for
IAXO-102
|
Properties | CAS |
1115270-63-7 |
|
2 Registered suppliers
Description : IAXO-102 is a TLR4 antagonist that modulates non-hematopoietic TLR4 proinflammatory signalling and inhibits experimental abdominal aortic aneurysm (AAA) development. Molecular Formula : C35H71NO5 Canonical SMILES : CCCCCCCCCCCCCCOC1C(C(OC(C1OCCCCCCCCCCCCCC)OC)CN)O InChI : InChI=1S/C35H71NO5/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-39-33-32(37)31(30-36)41-35(38-3)34(33)40-29-27-25-23-21-19-17-15-13-11-9-7-5-2/h31-35,37H,4-30,36H2,1-3H3/t31-,32-,33+,34-,35+/m1/s1 InChIKey : DJVFNDPRLMVKKO-KJQSSVQNSA-N Synonyms : IAXO-102; 1115270-63-7; CID 25222900; (2R,3R,4S,5R,6S)-2-(aminomethyl)-6-methoxy-4,5-di(tetradecoxy)oxan-3-ol; CHEMBL493017; SCHEMBL20239315; EX-A3691; AKOS037648519; BS-14387; HY-125171; CS-0089755; D70080; Methyl 6-amino-6-deoxy-2,3-di-O-tetradecyl-|A-D-glucopyranoside
More details are to be found here
Detailed information on the suppliers of
IAXO-102
|
Properties:
... more properties and specification on IAXO-102
|
|
Privileged suppliers
Last update 2024-06-07
|